This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boston Medical Center Corporation, Boston University, Northeastern University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 62 
2 out of 833 
2 out of 687 
Years Active: 2019
Title: Innovations of Sarah Haigh Molina in Cancer Therapeutics
Introduction
Sarah Haigh Molina is an accomplished inventor based in Boston, MA (US). She has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on novel agents for cancer treatment. Her work aims to inhibit cancer cell proliferation and metastasis, showcasing her dedication to advancing medical science.
Latest Patents
Molina's latest patents include innovative agents that modulate aryl hydrocarbon receptor (AhR) activity. These agents are designed for use in therapeutic compositions and methods to inhibit cancer cell proliferation and tumor cell invasion. The patents detail AhR inhibitors or non-constitutive AhR agonists of specific formulas, which are crucial for inhibiting cancer cell growth and addressing parameters that characterize tumor metastasis, such as tumor cell invasiveness.
Career Highlights
Throughout her career, Sarah Haigh Molina has worked with prestigious institutions, including Boston University and Northeastern University. Her research has focused on developing therapeutic strategies that leverage the modulation of AhR activity, contributing to the understanding and treatment of cancer.
Collaborations
Molina has collaborated with notable colleagues, including David H. Sherr and Michael Pollastri. These partnerships have enhanced her research efforts and expanded the impact of her innovations in cancer therapeutics.
Conclusion
Sarah Haigh Molina's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. Her patents and collaborations reflect her commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile